Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey

Abstract

Background Human papillomavirus (HPV) vaccine uptake among US adolescents is primarily dependent on the intent of their parents. To the best of our knowledge, an analysis quantifying parental intent to initiate and complete the HPV vaccine series in the USA at both the national and state level has not been done. We aim to estimate parental intent to initiate and complete the HPV vaccine series at the national-level and state-level and to identify reasons for lack of intent to initiate and complete the vaccine series.Methods This cross-sectional study uses data from the adolescent component of the 2017-18 National Immunization Survey (NIS-Teen). Study participants were parents or caregivers of US adolescents aged 13-17 years, who were most knowledgeable about the immunisation status of the adolescents. The primary outcome was parental intent to vaccinate the adolescent in the next 12 months. The secondary outcomes were (1) the prevalence of reasons given for lack of intent to initiate and complete the HPV vaccine series, and (2) the relationship between receiving a recommendation from a health-care provider to vaccinate and intent to initiate the vaccination series. We computed national-level and state-level estimates for parental lack of intent to initiate and to complete the vaccine series; population-level estimates were derived using survey weights. A survey design-adjusted Wald F test was used for bivariate analysis. A multivariate logistic regression model was used to examine the association between health-care provider recommendation and parental intent to initiate the series. Analyses were stratified by history of health-care provider recommendation to initiate the HPV vaccine series. FindingsIn 2017-18, the parent or caregiver of 82 297 US adolescents aged 13-17 years completed the NIS-Teen survey. 30 558 (37•1%) were unvaccinated and 9073 (10•8%) received only one HPV vaccine dose. Parents of 58•0% (17 171/29 086) of unvaccinated adolescents with data available on parental intent had no intention to initiate the HPV vaccine series. More than 65% of parents of unvaccinated adolescents in Idaho,

Squamous Cell Carcinoma of the Anus Incidence, Mortality, and Survival Among the General Population and Persons Living With HIV in Puerto Rico, 2000-2016

“… 38 Nonetheless, a recent HPV vaccine school entry policy established in 2018 in PR should have an impact on increasing uptake among adolescents within the next years, as the availability of school mandates seems to be a stronger driver for the improvement in vaccination rates. 39 …”

Preferences for a COVID-19 vaccine in Australia

“…Public trust in vaccines was significantly eroded by the pertussis vaccine controversy in the mid-1970s, and more recently by a publication in the Lancet proposing a causal relationship between the measles–mumps–rubella (MMR) vaccine and autism [39] . Other events that eroded public trust in vaccines include reporting of the H1N1 influenza vaccine increasing the risk of narcolepsy [33] , the RotaShield rotavirus vaccine causing intussusception in healthy infants [2] and the HPV vaccine safety recall in 2013 [36] .…”

Correcting HPV Vaccination Misinformation Online: Evaluating the HPV Vaccination NOW Social Media Campaign

“…According to the 2019 NIS-TEEN vaccination data that reports on HPV vaccination rates among adolescents in the U.S., 71.5% of all adolescents have received one or more doses and 54.2% of adolescent girls and boys are up-to-date on the HPV vaccine [ 10 ]. In a recent study among unvaccinated adolescents, 58% of parents indicated no intention to start the HPV vaccine series, revealing a significant public health issue [ 11 ].…”